Vaccine efficacy against HPV-31 / 33/45 for two-dose women who received their second dose at 6 months ( 681 % , 270-870 ; CVT data only ) , but not those receiving it at one month ( 101 % , -420 to 433 ) , was similar to the three-dose group .